Saloua Mrabet - Concepedia

Author

Saloua Mrabet

Also Known As

Bhim Singhal, Freek Verheul, Imen Mkada, Mrabet S, Mrabet Saloua, Riadh Gouider, S M'Rabet, S Mrabet, S. Mrabet, Saloua MRABET

199

Publications

826

Citations

H-Index

Concepts

All Affiliations

Tunis El Manar University Hôpital Razi de La Manouba Faculté de médecine de Tunis Tunis University Amiri Hospital

About

Saloua Mrabet is an author at Tunis El Manar University specializing in medicine, neurology, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	251
2	Public Health	3	3	105
3	Health Sciences	1	1	46
4	Social Sciences	1	1	11
5	Epidemiology	1	1	60

Saloua Mrabet

Publications

410

Citations

H-Index

Page 1

	Year	Citations
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region Bassem Yamout, Wassim Assaad, Hani Tamim, Multiple Sclerosis Journal - Experimental Translational and Clinical Neurological DisorderMedicineNeuroepidemiologyGlobal HealthGenetic Epidemiology	2020	60
Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines Bassem Yamout, Mohammed Aljumah, Mohammad Ali Sahraian, Multiple Sclerosis and Related Disorders Menactrims GuidelinesConsensus RecommendationsNeurological DisorderClinical NeurologyClinical Trials	2024	46
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19 Imen Kacem, Alya Gharbi, Chahida Harizi, Neurological Sciences Neurological DisorderNeurovirologyCovid-19 PandemicClinical NeurologyNeurological Symptoms	2020	45
Gastrointestinal Dysfunction and Neuropathologic Correlations in Parkinson Disease Saloua Mrabet, Nadia Ali, Afef Achouri-Rassas, Journal of Clinical Gastroenterology	2016	27
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries Sifat Sharmin, Izanne Roos, Charles B. Malpas, The Lancet Child & Adolescent Health Disease-modifying TherapiesNeurological DisorderDisabilityPediatricsPaediatric Medicine	2024	26
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable Sifat Sharmin, Izanne Roos, Steve Simpson, Brain	2023	25
Anti-Ma2-encephalitis in a 2 year-old child: A newly diagnosed case and literature review Saloua Mrabet, N. Ben Achour, Ichraf Kraoua, European Journal of Paediatric Neurology Pediatric HydrocephalusLiterature ReviewPediatricsNeurologyEncephalitis	2015	20
Clinical and genetic study of Tunisian families with genetic generalized epilepsy: contribution of CACNA1H and MAST4 genes Zied Landoulsi, Fatma Laatar, Eric Noé, Neurogenetics Mendelian DisorderGenetic DisorderGeneticsClinical GeneticsGenetic Epidemiology	2018	19
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis Tim Spelman, Gabrielle Simoneau, Robert Hyde, Neurology	2024	17
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies Wei Zhen Yeh, Anneke van der Walt, Olga Skibina, Neurology Neuroimmunology & Neuroinflammation	2024	16

Page 1